To investigate the potential regulators contributing to BACE1 posttranscriptional regulation, miR-107 was found to be downregulated early in AD by miRNA expression microarrays, and miR-107 targeting of the 3′UTR of BACE1 mRNA was biochemically validated [134]. The gene discussed is BACE1; the disease is Alzheimer disease.